Verywell Health on MSN12mon
Oxygen Therapy for COPD: Types, Benefits and How to Use O2
Medically reviewed by Daniel More, MD Chronic obstructive pulmonary disease (COPD) is a chronic lung disease. When someone ...
Pulmonology Advisor6d
Dupilumab Improves Symptoms, HRQOL in COPD With Type 2 Inflammation
Dupilumab vs placebo was linked to improved health-related quality of life and respiratory symptoms in patients with COPD and T2 inflammation.
6abc Action News8d
Balancing COPD with other chronic conditions
Many people with COPD have other conditions like diabetes or high cholesterol, too. Managing several conditions can be ...
European Medical Journal3d
Glucose-Lowering Medications Reduce COPD Exacerbation Risk
New research finds that SGLT-2is and GLP-1RAs are linked to lower risk of COPD exacerbations in patients with Type 2 diabetes ...
Pulmonology Advisor8d
Dupilumab Added to COPD Triple Therapy Reduces Moderate Exacerbations
Dupilumab added to standard COPD triple therapy reduces the annual rate of moderate exacerbations but not severe exacerbations.
Endocrinology Advisor15d
SGLT2 Inhibitors, GLP-1RAs Lower Risk for COPD Exacerbation in T2D
SGLT2 inhibitors and GLP-1RAs yielded lower risks for COPD exacerbation than DPP-4 inhibitors among patients with type 2 diabetes.
Medical Xpress1mon
Certain glucose-lowering meds associated with lower risk for COPD exacerbations
More information: Avik Ray et al, Glucose-Lowering Medications and Risk of Chronic Obstructive Pulmonary Disease Exacerbations in Patients With Type 2 Diabetes, JAMA Internal Medicine (2025).DOI ...
clinicaladvisor.com29d
Certain Glucose-Lowering Meds Associated With Lower Risk for COPD Exacerbations
Lower risk for COPD exacerbations seen with SGLT-2 inhibitors and GLP-1 receptor agonists, but not with DPP-4 inhibitors. HealthDay News — For patients with type 2 diabetes (T2D) and chronic ...